NRX Pharmaceuticals (NRXP)'s 30-day implied volatility (IV30) was 65.8% at the close on October 22, 2026, down from 74.2% the day before, against a 52-week range of 51.4% to 228.2%. Its 20-day historical volatility was 60.7%.
Data as of October 22, 2026.